April 25, 2022

Noram Lithium Corp (CVE:NRM, OTCMKTS:NRVTF) COO Peter Ball Interview

Midas Letter
Midas Letter
Noram Lithium Corp (CVE:NRM, OTCMKTS:NRVTF) COO Peter Ball Interview

Noram Lithium Corp (CVE:NRM, OTCMKTS:NRVTF) is a Canadian-based junior exploration company focused on advancing its Zeus Lithium Project to production in Nevada.

The Company’s high-grade Zeus Lithium Project in Clayton Valley, Nevada is located less than one mile from Albermarle’s Silver Peak Mine, which is currently the only lithium production facility in the United States.

The Zeus project has a NI 43-101 Technical Report highlighting a resource estimate (September 2021) of 363 million tonnes at 923 ppm lithium Measured & Indicated resources, and 827 million tonnes at 884 ppm lithium Inferred resources (400 ppm Li cut-off).

A Preliminary Economic Assessment (PEA) of the project was announced in December 2021 indicating:

  • $1.299 Billion Net Present Value (“NPV”). Base case after-tax Net Present Value (“NPV”) of $1.299 billion (8% discount rate).
  • 31% Internal Rate of Return (“IRR”). Base case after-tax IRR of 31%.
  • Capital Costs (“CAPEX”). Estimated initial CAPEX of $528M with after-tax payback period of 3.23 years.
  • Gross Revenue of $303.4 Million/year
  • Low Operating Cost. Operating Cost (“OPEX”) of $3,355.30/tonne Lithium Carbonate Equivalent (“LCE”) with a break-even price of $4016.6/tonne LCE LOM.


⚛️ Noram Lithium (CVE:NRM, OTCMKTS:NRVTF) COO Peter Ball interview (00:00)

💼 Business overview & updates (00:39)

⛏ Extracting lithium from clay process (02:37)

📈 Preliminary Economic Assessment (Dec 2021) & NPV (05:01)

💵 Cost of production (06:04)

💲 Waratah Capital Advisors financing (07:38)

💳 Cap Ex (08:06)

📊 Lithium grades (Li ppm) (09:55)

🤝 Off take partnerships (10:54)

🪫 Future lithium oversupply & lithium alternative batteries (12:05)

🇺🇸 Defense Production Act (13:28)


Midas Letter is provided as a source of information only, and is in no way to be construed as investment advice. James West, the author and publisher of the Midas Letter, is not authorized to provide investor advice, and provides this information only to readers who are interested in knowing what he is investing in and how he reaches such decisions.

Investing in emerging public companies involves a high degree of risk and investors in such companies could lose all their money. Always consult a duly accredited investment professional in your jurisdiction prior to making any investment decision.

Midas Letter occasionally accepts fees for advertising and sponsorship from public companies featured on this site. James West and/or Midas Letter may also receive compensation from companies affiliated with companies featured on this site. James West and/or Midas Letter also invests in companies on this site and so readers should view all information on this site as biased.